ODILIE REINOSA: Open Payments
NPI 1023170008 · PEMBROKE PINES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,249 in 71 payments from 15 companies in 2025. Trend: 2023 $1,541 · 2024 $1,097 · 2025 $1,249
Food & beverage: $1,249
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $247 |
| AstraZeneca Pharmaceuticals LP | 9 | $178 |
| Amgen Inc. | 13 | $172 |
| Lilly USA, LLC | 9 | $134 |
| Novartis Pharmaceuticals Corporation | 5 | $104 |
| Exact Sciences Corporation | 4 | $97 |
| PFIZER INC. | 4 | $88 |
| Abbott Laboratories | 2 | $41 |
| Dexcom, Inc. | 2 | $41 |
| ABBVIE INC. | 2 | $34 |
Products named: Ozempic, MOUNJARO, AIRSUPRA, Cologuard Collection Kit, OTEZLA, LEQVIO, Wegovy, REPATHA.
Industry payments across FL — which companies pay providers there.
